Correlation Between Balchem and Clarity Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Balchem and Clarity Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Balchem and Clarity Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Balchem and Clarity Pharmaceuticals, you can compare the effects of market volatilities on Balchem and Clarity Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Balchem with a short position of Clarity Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Balchem and Clarity Pharmaceuticals.
Diversification Opportunities for Balchem and Clarity Pharmaceuticals
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Balchem and Clarity is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Balchem and Clarity Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clarity Pharmaceuticals and Balchem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Balchem are associated (or correlated) with Clarity Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clarity Pharmaceuticals has no effect on the direction of Balchem i.e., Balchem and Clarity Pharmaceuticals go up and down completely randomly.
Pair Corralation between Balchem and Clarity Pharmaceuticals
Given the investment horizon of 90 days Balchem is expected to generate 6.18 times less return on investment than Clarity Pharmaceuticals. But when comparing it to its historical volatility, Balchem is 3.05 times less risky than Clarity Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Clarity Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 61.00 in Clarity Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 349.00 from holding Clarity Pharmaceuticals or generate 572.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 93.68% |
| Values | Daily Returns |
Balchem vs. Clarity Pharmaceuticals
Performance |
| Timeline |
| Balchem |
| Clarity Pharmaceuticals |
Balchem and Clarity Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Balchem and Clarity Pharmaceuticals
The main advantage of trading using opposite Balchem and Clarity Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Balchem position performs unexpectedly, Clarity Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clarity Pharmaceuticals will offset losses from the drop in Clarity Pharmaceuticals' long position.The idea behind Balchem and Clarity Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Clarity Pharmaceuticals vs. Legacy Education | Clarity Pharmaceuticals vs. Apple Inc | Clarity Pharmaceuticals vs. NVIDIA | Clarity Pharmaceuticals vs. Microsoft |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |